Projects per year
Personal profile
Education/Academic qualification
Breast Cancer, Hematology and Medical Oncology Fellowship Program, Houston Methodist
Jul 1 2018 → Jun 1 2021
Award Date: Jun 1 2021
Internal Medicine, Internal Medicine Residency Program, University of Arizona College of Medicine - Phoenix
Feb 1 2015
Award Date: Feb 1 2018
Medicine, Doctor of Medicine, Dayanand Medical College & Hospital
Jul 1 2007 → Jul 1 2013
Award Date: Jul 1 2013
External positions
Assistant Professor of Medicine, Weill Cornell Medical College
Apr 1 2025 → …
Divisions
- Medical Oncology
Fingerprint
Dive into the research topics where Akshjot Puri is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
IMPACT ON SURVIVAL OF FAITH-BASED SPIRITUAL CARE OR PSYCHOTHERAPY COMBINED WITH PALLIATIVE CARE VERSUS PALLIATIVE CARE ALONE IN PATIENTS WITH NON-CURATIVE MALIGNANCIES
Mai, H. P. (PI), Abanonu, C. (Key Personnel), Abdelrahim, M. (Key Personnel), Burns, E. A. (Key Personnel), Ganguly, S. (Key Personnel), Guan, J. (Key Personnel), Heyne, K. (Key Personnel), Mathur, S. (Key Personnel), Niravath, P. A. (Key Personnel), Pingali, S. R. (Key Personnel), Puri, A. (Key Personnel), Shah, S. (Key Personnel), Singh, M. (Key Personnel), Sun, K. (Key Personnel), Venta, L. A. (Key Personnel) & Zhang, J. (Key Personnel)
6/19/24 → …
Project: Clinical Trial
-
Fulvestrant Plus Abemaciclib With or Without Run-In of Fulvestrant in Er-Positive, Her2-Negative Metastatic Breast Cancer
Niravath, P. A. (PI), Abanonu, C. (Key Personnel), Guan, J. (Key Personnel), Heyne, K. (Key Personnel), Mai, H. P. (Key Personnel), Mathur, S. (Key Personnel), Puri, A. (Key Personnel) & Sun, K. (Key Personnel)
7/15/21 → …
Project: Clinical Trial
-
A Phase 3, Multicenter, Randomized, Open-Label, Active-Controlled Study of Trastuzumab Deruxtecan (T-DXd) Versus Trastuzumab Emtansine (T-DM1) in Participants With High-Risk HER2-Positive Primary Breast Cancer Who Have Residual Invasive Disease in Breast
Mai, H. P. (PI), Abanonu, C. (Key Personnel), Niravath, P. A. (Key Personnel), Puri, A. (Key Personnel), Shkedy, C. (Key Personnel), Sun, K. (Key Personnel) & Templeton, S. (Key Personnel)
Project: Clinical Trial
-
BO41843: Phase III_GDC-9545 RO7197597_Breast Cancer_Roche BO41843: A Phase III Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating the Efficacy and Safety of GDC-9545 Combined With Palbociclib Compared With Letrozole Combined With Palbociclib in Patients With Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer
Niravath, P. A. (PI), Abanonu, C. (Key Personnel), Mai, H. P. (Key Personnel), Puri, A. (Key Personnel) & Sun, K. (Key Personnel)
Project: Clinical Trial
-
Multicenter Phase I/Ib Trial of Olaparib in Combination With Vorinostat in Patients With Relapsed/Refractory and/or Metastatic Breast Cancer
Niravath, P. A. (PI), Abanonu, C. (Key Personnel), Guan, J. (Key Personnel), Puri, A. (Key Personnel) & Sun, K. (Key Personnel)
Project: Clinical Trial
-
Hydroxytyrosol, a Component of Olive Oil for Breast Cancer Prevention in Women at High Risk of Cancer
Puri, A., Yin, Z., Granados-Principal, S., Ensor, J., Guzman, L., Rosato, R., Zhao, H., Wong, S., Wang, L., Patel, T. & Chang, J. C., 2025, In: International Journal of Breast Cancer. 2025, 1, 8831168.Research output: Contribution to journal › Article › peer-review
Open Access -
Spatial Crosstalk Modeling of the Tumor Microenvironment Identifies CCR5-Mediated Glia-to-Glia Signaling as a Key Regulator of Brain Metastatic Progression
Ahn, J. Y., Dong, W., Puri, A., Vasquez, M., Raghunathan, R., Yang, L., Sheng, J., Zhao, H. & Wong, S. T. C., Sep 16 2025, (E-pub ahead of print) In: Cancer research.Research output: Contribution to journal › Article › peer-review
-
NOS inhibition sensitizes metaplastic breast cancer to PI3K inhibition and taxane therapy via c-JUN repression
Reddy, T., Puri, A., Guzman-Rojas, L., Thomas, C., Qian, W., Zhou, J., Zhao, H., Mahboubi, B., Oo, A., Cho, Y. J., Kim, B., Thaiparambil, J., Rosato, R., Martinez, K. O., Chervo, M. F., Ayerbe, C., Giese, N., Wink, D., Lockett, S. & Wong, S. & 7 others, , Dec 2024, In: Nature Communications. 15, 1, 10737.Research output: Contribution to journal › Article › peer-review
Open Access5 Scopus citations -
Clinical factors and association with treatment modalities in patients with breast cancer and brain metastases who develop leptomeningeal metastases
Puri, A., Mylavarapu, C., Xu, J., Patel, T., S.Teh, B., Tremont-Lukats, I., Chang, J. C. & Niravath, P., Jun 2022, In: Breast Cancer Research and Treatment. 193, 3, p. 613-623 11 p.Research output: Contribution to journal › Article › peer-review
5 Scopus citations -
Skeletal metastases in advanced pancreatic ductal adenocarcinoma: A retrospective analysis
Puri, A., Chang, J., Tanner, N., Lucente, P., Desiongco, J., Dragovich, T., Naraev, B. & Kundranda, M., Apr 2021, In: Journal of Gastrointestinal Oncology. 12, 2, p. 455-463 9 p.Research output: Contribution to journal › Article › peer-review
Open Access4 Scopus citations